Browsing by Subject "Dopamine, neurodegeneration"
Now showing items 1-1 of 1
-
(Springer, 2016)L-Dopa continues to be the gold drug in Parkinson's disease ( PD) treatment from 1967. The failure to translate successful results from preclinical to clinical studies can be explained by the use of preclinical models which ...